Podcast on the Management of Adverse Events Associated with Lorlatinib

被引：0
|
作者：
Bauer, Todd M. [1 ,2 ]
Bertino, Erin M. [3 ]
机构：
[1] Sarah Cannon Canc Res Inst, 250 25th Ave, Nashville, TN 37203 USA
[2] Tennessee Oncol PLLC, 250 25th Ave, Nashville, TN 37203 USA
[3] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA
来源：
ADVANCES IN THERAPY | 2022年 / 39卷 / 04期
关键词：
Adverse events; Lorlatinib; Lung cancer; Oncology; Podcast; CELL LUNG-CANCER; PREFERRED 1ST-LINE OPTION; ALK; PF-06463922; CRIZOTINIB; INHIBITOR; ROS1;
D O I：
10.1007/s12325-022-02050-3
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[media not available: see fulltext]
引用
收藏
页码：1447 / 1456
页数：10
相关论文
共 50 条
  • [1] Podcast on the Management of Adverse Events Associated with Lorlatinib
    Todd M. Bauer
    Erin M. Bertino
    [J]. Advances in Therapy, 2022, 39 : 1447 - 1456
  • [2] Clinical Management of Adverse Events Associated with Lorlatinib
    Bauer, Todd M.
    Felip, Enriqueta
    Solomon, Benjamin J.
    Thurm, Holger
    Peltz, Gerson
    Chioda, Marc D.
    Shaw, Alice T.
    [J]. ONCOLOGIST, 2019, 24 (08): : 1103 - 1110
  • [3] Recent Advances in the Management of Adverse Events Associated with Lorlatinib
    Liao, Dehua
    Zhang, Jiwen
    Yan, Ting
    Chen, Shanshan
    Li, Wei
    Shangguan, Dangang
    She, Zhihua
    [J]. ONCOTARGETS AND THERAPY, 2023, 16 : 731 - 738
  • [4] A pragmatic guide for management of adverse events associated with lorlatinib
    Liu, Geoffrey
    Mazieres, Julien
    Stratmann, Jan
    Ou, Sai-Hong Ignatius
    Mok, Tony
    Grizzard, Mary
    Goto, Yasushi
    Felip, Enriqueta
    Solomon, Benjamin J.
    Bauer, Todd M.
    [J]. LUNG CANCER, 2024, 191
  • [5] CONSENSUS RECOMMENDATIONS FOR MANAGEMENT AND COUNSELING OF ADVERSE EVENTS ASSOCIATED WITH LORLATINIB
    Hronek, Jan W.
    Kettle, Jacob K.
    Jamil, Ahsan
    Devgan, Geeta
    Chioda, Marc D.
    Reed, Mollie
    [J]. ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [6] Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners
    Mollie Reed
    Aimee-Lauren S. Rosales
    Marc D. Chioda
    Lindsey Parker
    Geeta Devgan
    Jacob Kettle
    [J]. Advances in Therapy, 2020, 37 : 3019 - 3030
  • [7] Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners
    Reed, Mollie
    Rosales, Aimee-Lauren S.
    Chioda, Marc D.
    Parker, Lindsey
    Devgan, Geeta
    Kettle, Jacob
    [J]. ADVANCES IN THERAPY, 2020, 37 (06) : 3019 - 3030
  • [8] Neurocognitive Adverse Events of Lorlatinib: On the Way to Precise Prediction?
    Jia, Keyi
    Ren, Shengxiang
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (01) : 26 - 28
  • [9] Management of Carfilzomib-Associated Cardiac Adverse Events
    Mikhael, Joseph
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (05): : 241 - 245
  • [10] PRACTICAL MANAGEMENT OF ADVERSE EVENTS ASSOCIATED WITH AFATINIB.
    Sipples, Rebecca
    Andan, Christine
    Eaby-Sandy, Beth
    [J]. ONCOLOGY NURSING FORUM, 2015, 42 (02) : E220 - E221
12345